Media Releases - 2009

	Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business
	Orchid registers revenue of Rs 314 crore during Q2 FY10
	Orchid awarded the Corporate Social Responsibility Award 2008-09 by Government of Tamilnadu
	Update note on Piperacillin-Tazobactam
	Information note on Piperacillin-Tazobactam
	Orchid receives final US FDA nod for Zaleplon Capsules
	Orchid’s Piperacillin-Tazobactam ANDAs receive US FDA nod Granted 180-days generic drug exclusivity
	Orchid receives Final US FDA nod for Sumatriptan Tablets
	Orchid Chemicals & Pharmaceuticals Ltd (Orchid) and Schering-Plough Corporation (SGP) Settle Clarinex® and Clarinex® RediTabs® Patent Lawsuits
	Orchid registers turnover of Rs 309 crore during Q1 FY10
	Orchid receives US FDA approval for Amlodipine Besylate Tablets
	Orchid registers a turnover of Rs 1211 crore during FY09 Board recommends dividend of 10%
	Orchid receives Tentative US FDA nod for Sumatriptan Tablets
	Orchid’s facility conferred global recognition Awarded the 2009 Facility of the Year Award in Regional Excellence Category
	Orchid registers turnover of Rs 310 crore during Q3 FY09 Maintains operational profitability (PBT) at Rs 28 crore
	Orchid receives US FDA approval for Levetiracetam Tablets